Search CommunityWalk:


Celek Pharmaceuticals LLC

9700 Great Seneca Highway, Ste. 132
Rockville, MD 20850, USA

Category: Biotechnology/Biopharmaceutical

Used in the following map:

Maryland Biotech Industry Map

Celek Pharmaceuticals LLC addresses the need for new medicines to help patients suffering from cancers that lack effective treatment options. The company was founded in the year 2009.

Celek focuses on the development of targeted therapies for bladder cancer, a prevalent yet underserved disease in need of safer and more effective treatments. Bladder cancer is the non-muscle invasive disease (NMIBC) which involves transurethral resection of the tumor, often followed by intravesical (i.e., transurethrally instilled) cytotoxic chemotherapy or immunotherapy with Bacillus Calmette-Guerin (BCG).

Celek's lead oncology product CEL-031, targets cGMP phosphodiesterases in cancer cells to induce selective programmed cell death. It has obtained exclusive rights to its lead anti-cancer compound, CEL-031, from OSI Pharmaceuticals which is a member of the Astellas group of companies.